Ultra VIX Short-Term Fut ETF Proshares (UVXY) 15.26

New Post Public Reply Private Reply Replies (0) Message Board

Mar 22, 2015 at 12:53 AM

Ultra VIX Short-Term Fut ETF Proshares (UVXY) 15.26 $UVXY

How Does UVXY Work?
Vance Harwood - Seeking Alpha - Thu Mar 19, 3:41AM CDT
Exchange Trade Fund ProShares Ultra VIX Short-Term Futures (NYSEARCA: UVXY ) and its Exchange Traded Note cousin VelocityShares Daily 2x VIX Short-Term (NASDAQ: TVIX ) are 2X leveraged funds that track short-term volatility. To have a good...
UVXY: 15.26 (-0.46)

Long VIX ETPs seeing lots of action ahead of FOMC
Seeking Alpha - at Seeking Alpha - Tue Mar 17, 12:33PM CDT

TVIZ: 18.95 (-0.28), TVIX: 1.73 (-0.06), XVZ: 28.51 (+0.20), VIXM: 60.81 (+0.37), XVIX: 16.69 (+0.26), ZIV: 42.37 (-0.25), VXX: 25.73 (-0.40), IVOP: 38.01 (+0.13), UVXY: 15.26 (-0.46), VIIX: 34.73 (-0.55), CVOL: 0.79 (unch), VXZ: 12.49 (+0.07), VIIZ: 17.14 (+0.03), XXV: 38.28 (+0.02), SVXY: 67.98 (+1.12), XIV: 34.63 (+0.54), VIXY: 17.10 (-0.28)

March Madness - Dividend Grandness And Volatility Blandness
Wade Slome, CFA - at Seeking Alpha - Tue Mar 17, 12:37AM CDT
March Madness has arrived once again. This NCAA basketball event, which has been around since 1939, begins with a selection committee choosing the top 68 teams in the country. These teams are matched up against each other through a single-elimination...
TVIZ: 18.95 (-0.28), TVIX: 1.73 (-0.06), VIXM: 60.81 (+0.37), XVIX: 16.69 (+0.26), VXX: 25.73 (-0.40), IVOP: 38.01 (+0.13), UVXY: 15.26 (-0.46), CVOL: 0.79 (unch), VXZ: 12.49 (+0.07), XIV: 34.63 (+0.54), SVXY: 67.98 (+1.12), XVZ: 28.51 (+0.20), SPY: 210.41 (+0.91), QQQ: 108.53 (+0.45), ZIV: 42.37 (-0.25), DIA: 180.96 (+1.30), VIIX: 34.73 (-0.55), VIIZ: 17.14 (+0.03), XXV: 38.28 (+0.02), VIXY: 17.10 (-0.28)

Make 70% A Year With Math: Part 2
Harry Long - at Seeking Alpha - Fri Mar 13, 4:00PM CDT

TVIX: 1.73 (-0.06), SPY: 210.41 (+0.91), UVXY: 15.26 (-0.46), TMV: 26.26 (-0.43)

VXX - Our Short Captured 15% In 1 Month, But Volatility Is Back
Markos Kaminis - at Seeking Alpha - Wed Mar 11, 7:28PM CDT

TVIX: 1.73 (-0.06), SPY: 210.41 (+0.91), VXX: 25.73 (-0.40), UVXY: 15.26 (-0.46), XIV: 34.63 (+0.54)

UVXY: Large Inflows Detected at ETF
ETFChannel.com - Thu Mar 05, 10:42AM CST
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares Ultra VIX Short-Term Futures ETF where we have detected an approximate $118.6 million dollar inflow -- that's...
UVXY: 15.26 (-0.46)

What To Do With Quiet Markets?
Adam Grimes - at Seeking Alpha - Wed Mar 04, 1:47PM CST
Just a high level perspective on what we have going on in a few major markets this week. In general, most markets are in some kind of volatility compression . Volatility compression is a term that basically means current volatility conditions are...
TVIX: 1.73 (-0.06), SPY: 210.41 (+0.91), QQQ: 108.53 (+0.45), VXX: 25.73 (-0.40), IVOP: 38.01 (+0.13), DIA: 180.96 (+1.30), UVXY: 15.26 (-0.46), VIIX: 34.73 (-0.55), XXV: 38.28 (+0.02), VIXY: 17.10 (-0.28), SVXY: 67.98 (+1.12), XIV: 34.63 (+0.54)

It Might Be Time To Buy Volatility
Orange Peel Investments - at Seeking Alpha - Mon Mar 02, 4:36PM CST

VXX: 25.73 (-0.40), GLD: 113.57 (+1.28), UVXY: 15.26 (-0.46)

Equity Volatility - Going Higher
Macronomics - Seeking Alpha - Mon Mar 02, 9:12AM CST
"When dealing with people, remember you are not dealing with creatures of logic, but creatures of emotion." - Dale Carnegie, American writer Please find below a great guest post from our good friends at Rcube Global Asset Management ...
TVIZ: 18.95 (-0.28), TVIX: 1.73 (-0.06), VIXM: 60.81 (+0.37), XVIX: 16.69 (+0.26), VXX: 25.73 (-0.40), IVOP: 38.01 (+0.13), UVXY: 15.26 (-0.46), VXZ: 12.49 (+0.07), CVOL: 0.79 (unch), XIV: 34.63 (+0.54), SVXY: 67.98 (+1.12), EEM: 40.08 (+0.59), XVZ: 28.51 (+0.20), ZIV: 42.37 (-0.25), VIIX: 34.73 (-0.55), VIIZ: 17.14 (+0.03), XXV: 38.28 (+0.02), VIXY: 17.10 (-0.28)

Why I Am Hedging My Portfolio With UVXY
Dan Carman - at Seeking Alpha - Mon Feb 23, 8:05PM CST

UVXY: 15.26 (-0.46)

The VIX: What It Is, What It Isn't, What To Do About It Now
Peter F. Way, CFA - at Seeking Alpha - Mon Feb 23, 4:17PM CST

VIXM: 60.81 (+0.37), VXX: 25.73 (-0.40), UVXY: 15.26 (-0.46), VIIX: 34.73 (-0.55), SVXY: 67.98 (+1.12), VIXY: 17.10 (-0.28)

U.S. Equity Volatility Is 'Back To Average'
ValueWalk - at Seeking Alpha - Wed Feb 11, 3:30AM CST
By Michael Ide Morgan Stanley says that it's understandable that volatility us up for most asset classes, but sees room for US equity volatility to fall again. Volatility is up across the board, in some cases from historic lows to recent highs,...
TVIX: 1.73 (-0.06), VXX: 25.73 (-0.40), IVOP: 38.01 (+0.13), UVXY: 15.26 (-0.46), VIIX: 34.73 (-0.55), XXV: 38.28 (+0.02), VIXY: 17.10 (-0.28), SVXY: 67.98 (+1.12), XIV: 34.63 (+0.54)

Short-Term VIX Futures Products Should Be Avoided Until Better Opportunities Arise
Nathan Buehler - at Seeking Alpha - Mon Feb 09, 2:03PM CST

VXX: 25.73 (-0.40), UVXY: 15.26 (-0.46), XIV: 34.63 (+0.54), SVXY: 67.98 (+1.12)

iPath S&P 500 VIX - Why I'm Selling The VIX Here
Markos Kaminis - at Seeking Alpha - Wed Feb 04, 1:13PM CST

TVIX: 1.73 (-0.06), MTUM: 72.34 (+0.54), SPY: 210.41 (+0.91), VXX: 25.73 (-0.40), ZIV: 42.37 (-0.25), UVXY: 15.26 (-0.46), OIL: 9.79 (+0.22), NBG: 1.34 (+0.14), XIV: 34.63 (+0.54)

The Year In VIX And Volatility - 2014
Bill Luby - at Seeking Alpha - Mon Jan 26, 11:05PM CST
This is the seventh year in a row I have offered a retrospective look at the year in VIX and Volatility, which is my attempt to cram some of the highlights of the year in volatility onto one graphic with a (somewhat) manageable number of annotations....
TVIZ: 18.95 (-0.28), TVIX: 1.73 (-0.06), XVZ: 28.51 (+0.20), VIXM: 60.81 (+0.37), XVIX: 16.69 (+0.26), ZIV: 42.37 (-0.25), VXX: 25.73 (-0.40), IVOP: 38.01 (+0.13), UVXY: 15.26 (-0.46), VIIX: 34.73 (-0.55), CVOL: 0.79 (unch), VXZ: 12.49 (+0.07), VIIZ: 17.14 (+0.03), XXV: 38.28 (+0.02), VIXY: 17.10 (-0.28), SVXY: 67.98 (+1.12), XIV: 34.63 (+0.54)

One Reason Why The New VIX Calculation Is Better
Vance Harwood - at Seeking Alpha - Tue Jan 13, 5:02PM CST
The CBOE changed the way the VIX® was calculated on October 6th, 2014- asserting the change would provide a more accurate assessment of expected volatility. The new process does look better to me, but I've been surprised that the new VIX and the...
TVIZ: 18.95 (-0.28), TVIX: 1.73 (-0.06), XVZ: 28.51 (+0.20), VIXM: 60.81 (+0.37), XVIX: 16.69 (+0.26), ZIV: 42.37 (-0.25), VXX: 25.73 (-0.40), IVOP: 38.01 (+0.13), UVXY: 15.26 (-0.46), VIIX: 34.73 (-0.55), CVOL: 0.79 (unch), VXZ: 12.49 (+0.07), VIIZ: 17.14 (+0.03), XXV: 38.28 (+0.02), VIXY: 17.10 (-0.28), SVXY: 67.98 (+1.12), XIV: 34.63 (+0.54)

The Current VIX Landscape Deserves Risk Assessments
Nathan Buehler - at Seeking Alpha - Wed Jan 07, 1:08AM CST

UVXY: 15.26 (-0.46), SVXY: 67.98 (+1.12)

After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Dec 26, 4:35PM CST

TVIX: 1.73 (-0.06), IHT: 2.64 (unch), BLCM: 25.19 (-0.71), VXX: 25.73 (-0.40), JNUG: 20.45 (+2.15), UVXY: 15.26 (-0.46), RLGY: 44.66 (+0.74), JD: 29.11 (+0.17), JDST: 10.36 (-1.39), SVXY: 67.98 (+1.12)

The Most Consistent Risk/Reward Speculation That I Have Ever Found
Scott Brown - Seeking Alpha - Fri Dec 19, 1:54PM CST
Everyone loves a good speculation. The problem is that every good speculation has a good bit of risk associated with it, thus the reason why it is considered speculation and not an investment. I've heard all sorts of market "experts" that...
EDZ: 33.42 (-1.54), TZA: 9.88 (-0.26), JNUG: 20.45 (+2.15), UVXY: 15.26 (-0.46), TNA: 92.59 (+2.29), DUST: 16.25 (-1.88), EDC: 23.63 (+0.95), NUGT: 11.26 (+1.03), SVXY: 67.98 (+1.12), JDST: 10.36 (-1.39)

Current Events Provide A VIX Opportunity
Nathan Buehler - Seeking Alpha - Mon Dec 15, 10:35AM CST
Hello everyone! I am happy to be back writing. During the school year, I get very bogged down from August to November. Luckily, academics are going well and things have begun to taper off towards Christmas. Next semester, I am teaching day and night...
UVXY: 15.26 (-0.46), SVXY: 67.98 (+1.12)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

CARsgen's CAR-T Breakthrough on China's Insurance List

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

PASCAL's Holiday Gift Edit: Timeless Watches Shine

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Luvme Hair Offers Wig Variety for Winter Fashion

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

WHO and RCSI Bahrain Join Forces on Health Initiatives

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...